The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors

European Journal of Neuroscience

Volumn 22, Issue 6, 2005, Pages 1417-1430

  El Bahh, Bouchaïb ^a,g   Balosso, Silvia ^b   Hamilton, Trevor ^a   Herzog, Herbert ^c   Beck Sickinger, Annette G ^d   Sperk, Günther ^e   Gehlert, Donald R ^f   Vezzani, Annamaria ^b   Colmers, William F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f ELI LILLY AND COMPANY   (United States)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

BIIE0246; Epilepsy; Neuropeptide Y; Presynaptic inhibition; Y2 knockout mouse; Y5 receptors

Indexed keywords

2 NITROBENZENE 2 SULFONIC ACID [4 (2 NAPHTHYLMETHYLAMINO)METHYLCYCLOHEXYLMETHYL]AMIDE; GW 438014A; KAINIC ACID; N [1 (2 PHENYLETHYL) 1H BENZIMIDAZOL 2 YL]BENZAMIDE METHANESULFONATE; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; AUTORADIOGRAPHY; BRAIN SLICE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; EVOKED RESPONSE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTICONVULSANTS; ARGININE; AUTORADIOGRAPHY; BENZAZEPINES; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MAGNESIUM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; RATS; RECEPTORS, NEUROPEPTIDE Y; SEIZURES; SYNAPSES;

EID: 26644470063     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04338.x     Document Type: Article

References (56)

1. Baraban, S.C. (2002) Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors. Epilepsia, 43 (Suppl. 5), 9-13.
2. Baraban, S.C., Hollopeter, G., Erickson, J.C., Schwartzkroin, P.A. & Palmiter, R.D. (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci., 17, 8927-8936.
3. Benmaamar, R., Richichi, C., Gobbi, M., Daniels, A.J., Beck-Sickinger, A.G. & Vezzani, A. (2005) Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats. Reg. Pept., 125, 79-83.
4. Bregola, G., Dumont, Y., Founder, A., Zucchini, S., Quirion, R. & Simonato, M. (2000) Decreased levels of neuropeptide Y (5) receptor binding sites in two experimental models of epilepsy. Neuroscience, 98, 697-703.
5. 5 receptor increases food intake in rats. J. Biol. Chem., 275, 36043-36048.
6. Clark, S. & Wilson, W.A. (1992) Brain slice model of epilepsy: neuronal networks and actions of antiepileptic drugs. In: Faingold, C.L. & Fromm, G.H. (Eds), Drugs for Control of Epilepsy: Actions on Neuronal Networks Involved in Seizure Disorders. CRC Press, Boea Raton, Florida, pp. 89-123.
7. 2 receptor. Br. J. Pharmacol., 102, 41-44.
8. Colmers, W.F., Lukowiak, K. & Pittman, Q.J. (1987) Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J. Physiol. (Lond.), 383, 285-299.
9. Colmers, W.F., Pronchuk, N., Torok-Both, C., Ho, M., Aronyk, K., McKean, J., Snyder, T., Sinclair, D.B., Javidan, M. & Beck-Sickinger, A.G. (1997) Neuropeptide Y2 and other receptors inhibit synaptic excitation in epileptic human brain. Epilepsia, 38 (Suppl. 8), 12.
10. Daniels, A.J., Grizzle, M.K., Wiard, R.P., Matthews, J.E. & Heyer, D. (2002) Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist. Regul. Pept., 106, 47-54.
11. Doods, H., Gaida, W., Wieland, H.A., Dollinger, H., Schnorrenberg, G., Esser, F., Engel, W., Eberlein, W. & Rudolf, K. (1999) BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
12. Dumont, Y., Fournier, A. & Quirion, R. (1998) Expression and characterization of the Neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci., 18, 5565-5574.
13. 125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse, 22, 139-158.
14. Dumont, Y., Moyse, E., Fournier, A. & Quirion, R. (2005) Evidence for the existence of an additional class of Neuropeptide Y receptor sites in the rat brain. J. Pharmacol. Exp. Ther., in press. [doi:10.1124/jpet.105.089300]
15. El Bahh, B., Cao, J.Q., Beck-Sickinger, A.G. & Colmers, W.F. (2002) Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br. J. Pharmacol., 136, 502-509.
16. Erickson, J.C., Clegg, K.E. & Palmiter, R.D. (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 381, 415-421.
17. Fürtinger, S., Pirker, S., Czech, T., Baumgartner, C., Ransmayr, G. & Sperk, G. (2001) Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J. Neurosci., 21, 5804-5812.
18. Gehlert, D.R., Schober, D.A., Beavers, L., Gadski, R.A., Hoffman, J.A., Chance, R., Lundell, I. & Larhammar, D. (1996) Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide preferring (PP1) receptor. Mol. Pharmacol., 50, 112-118.
19. Gehlert, D.R., Yang, P., George, C., Schober, D.A., Gackenheimer, S.L., Johnson, D., Beavers, L.S., Gadski, R.A. & Baez, M. (2001) Cloning and characterization of rhesus neuropeptide Y Y1, Y2 and Y5 Receptors. Peptides, 22, 343-350.
20. Gobbi, M., Gariboldi, M., Piwko, C., Hoyer, D., Sperk, G. & Vezzani, A. (1998) Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J. Neurochem., 70, 1615-1622.
21. Greber, S., Schwarzer, C. & Sperk, G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol., 113, 737-740.
22. 5 receptors mediate inhibition of synaptic excitation in proximal subiculum, but do not suppress epileptiform activity in rat hippocampal slices. J. Neurophysiol., 83, 723-734.
23. Howell, O.W., Scharfman, H.E., Beck-Sickinger, A.G., Herzog, H. & Gray, W.P. (2003) Neuropeptide Y is neuroproliferative in primary hippocampal cultures. J. Neurochem., 86, 646-659.
24. 2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br. J. Pharmacol., 105, 470-474.
25. Klapstein, G.J. & Colmers, W.F. (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol., 78, 1651-1661.
26. Kofler, N., Kirchmair, E., Schwarzer, C. & Sperk, G. (1997) Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett., 230, 129-132.
27. Kopp, J., Nanobashvili, A., Kokaia, Z., Lindvall, O. & Hökfelt, T. (1999) Differential regulation of mRNA's for Neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Brain Res. Mol. Brain Res., 72, 17-29.
28. 125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s). Neuropeptides., 39, 21-28.
29. Marsh, D.J., Baraban, S.C., Hollopeter, G. & Palmiter, R.D. (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl Acad. Sci. USA, 96, 13518-13523.
30. McQuiston, A.R. & Colmers, W.F. (1996) Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol., 76, 3159-3168.
31. Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. & Westfall, T. (1998) XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
32. Mody, I., Lambert, J.D.C. & Heinemann, U. (1987) Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol., 57, 869-888.
33. Patrylo, P.R., van den Pol, A.N., Spencer, D.D. & Williamson, A. (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J. Neurophysiol., 82, 478-483.
34. Pronchuk, N., Beck-Sickiriger, A.G. & Colmers, W.F. (2002) Presynaptic action by multiple neuropeptide Y receptors modulates GABAergic transmission in paraventricular nucleus of rat hypothalamus. Endocrinology, 143, 535-543.
35. 2+ entry. J. Neurosci., 17, 8169-8177.
36. Reibel, S., Benmaamar, R., Le, B.T., Larmet, Y., Kalra, S.P., Marescaux, C. & Depaulis, A. (2003) Neuropeptide Y delays hippocampal kindling in the rat. Hippocampus, 13, 557-560.
37. Richichi, C., Lin, E.J., Stefanin, D., Colella, D., Ravizza, T., Grignaschi, G., Veglianese, P., Sperk, G., During, M.J. & Vezzani, A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci., 24, 3051-3059.
38. Rist, B., Wieland, H.A., Willim, K.D. & Beck-Sickinger, A.G. (1995) A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J. Pept. Sci., 1, 341-348.
39. Sainsbury, A., Schwarzer, C., Couzens, M., Fetissov, S., Fürtinger, S., Jenkins, A., Cox, H.M., Sperk, G., Hokfelt, T. & Herzog, H. (2002) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc. Natl Acad. Sci. USA, 99, 8938-8943.
40. Schwarzer, C., Kofler, N. & Sperk, G. (1998) Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol., 53, 6-13.
41. Schwarzer, C., Williamson, J.M., Lothman, E.W., Vezzani, A. & Sperk, G. (1995) Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience, 69, 831-845.
42. Silva, A.P., Carvalho, A.P., Carvalho, C.M. & Malva, J.O. (2003) Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology, 44, 282-292.
43. 1-receptor. Eur. J. Biochem., 268, 2828-2837.
44. Sperk, G. (1994) Kainic acid seizures in the rat. Prog. Neurobiol., 42, 1-32.
45. Sperk, G., Marksteiner, J., Gruber, B., Bellmann, R., Mahata, M. & Ortler, M. (1992) Functional changes in neuropeptide Y- and somatostatin- containing neurons induced by limbic seizures in the rat. Neuroscience, 50, 831-846.
46. Stasheff, S.F., Bragdon, A.C. & Wilson, W.A. (1985) Induction of epileptiform activity in hippocampal slices by trains of electrical stimuli. Brain Res., 344, 296-302.
47. Sun, Q.Q., Akk, G., Huguenard, J.R. & Prince, D.A. (2001) Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J. Physiol. (Lond.), 531, 81-94.
48. Toth, P.T., Bindokas, V.P., Bleakman, D., Colmers, W.F. & Miller, R.J. (1993) Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature, 364, 635-639.
49. Tu, B., Timofeeva, O., Jiao, Y. & Nadler, J.V. (2005) Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J. Neurosci., 25, 1718-1729.
50. Vezzani, A., Michalkiewicz, M., Michalkiewicz, T., Moneta, D., Ravizza, T., Richichi, C., Aliprandi, M., Mule, F., Pirona, L., Gobbi, M., Schwarzer, C. & Sperk, G. (2002) Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience, 110, 237-243.
51. Vezzani, A., Moneta, D., Conti, M., Richichi, C., Ravizza, T., De Luigi, A., De Simoni, M.G., Sperk, G., Andell-Jonsson, S., Lundkvist, J., Iverfeldt, K. & Bartfai, T. (2000) Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl Acad. Sc. USA, 97, 11534-11539.
52. Vezzani, A. & Sperk, G. (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides, 38, 245-252.
53. Vezzani, A., Sperk, G. & Colmers, W.F. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci., 22, 25-30.
54. Wieland, H.A., Engel, W., Eberlein, W., Rudolf, K. & Doods, H.N. (1998) Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol., 125, 549-555.
55. Woldbye, D.P., Larsen, P.J., Mikkelsen, J.D., Klemp, K., Madsen, T.M. & Bolwig, T.G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nature Med., 3, 761-764.
56. Zhang, C.L., Dreier, J.P. & Heinemann, U. (1995) Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res., 20, 105-111.